Guiyang Xintian Pharmaceutical Co Ltd Total Liabilities
Guiyang Xintian Pharmaceutical Co Ltd total liabilities. Based on the latest financial reports, Guiyang Xintian Pharmaceutical Co Ltd (002873) has total liabilities worth CN¥832.04 Million CNY (≈ $121.75 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 002873 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Guiyang Xintian Pharmaceutical Co Ltd (2012–2025)
Total liabilities of Guiyang Xintian Pharmaceutical Co Ltd from 2012 to 2025. This chart illustrates how Guiyang Xintian Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data.
Guiyang Xintian Pharmaceutical Co Ltd Competitors by Total Liabilities
The table below lists competitors of Guiyang Xintian Pharmaceutical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Fujian Yuanxiang New Materials Co. Ltd. A
SHE:301300
|
China | CN¥180.56 Million |
|
First of Long Island Corp
NASDAQ:FLIC
|
USA | $3.69 Billion |
|
Nivika Fastigheter AB Series B
ST:NIVI-B
|
Sweden | Skr8.36 Billion |
|
Sunlour Pigment CO.LTD.
SHE:301036
|
China | CN¥951.31 Million |
|
H.G. Infra Engineering Limited
NSE:HGINFRA
|
India | Rs76.20 Billion |
|
Thoresen Thai Agencies Public Company Limited
BK:TTA
|
Thailand | ฿17.93 Billion |
|
Nalwa Sons Investments Limited
NSE:NSIL
|
India | Rs-152.19 Billion |
Liability Composition Analysis (2012–2025)
This chart breaks down Guiyang Xintian Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 002873 asset base.
Liquidity & Leverage Metrics
Guiyang Xintian Pharmaceutical Co Ltd Total Liabilities Ratios Explained
Guiyang Xintian Pharmaceutical Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.34 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.66 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.40 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Guiyang Xintian Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Guiyang Xintian Pharmaceutical Co Ltd (2012–2025)
The table below shows the annual total liabilities of Guiyang Xintian Pharmaceutical Co Ltd from 2012 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥864.83 Million ≈ $126.55 Million |
+14.43% |
| 2024-12-31 | CN¥755.79 Million ≈ $110.60 Million |
-5.35% |
| 2023-12-31 | CN¥798.47 Million ≈ $116.84 Million |
+11.73% |
| 2022-12-31 | CN¥714.65 Million ≈ $104.58 Million |
+12.72% |
| 2021-12-31 | CN¥633.98 Million ≈ $92.77 Million |
-10.41% |
| 2020-12-31 | CN¥707.64 Million ≈ $103.55 Million |
+88.76% |
| 2019-12-31 | CN¥374.89 Million ≈ $54.86 Million |
+15.81% |
| 2018-12-31 | CN¥323.72 Million ≈ $47.37 Million |
+38.17% |
| 2017-12-31 | CN¥234.30 Million ≈ $34.29 Million |
-13.33% |
| 2016-12-31 | CN¥270.33 Million ≈ $39.56 Million |
-0.99% |
| 2015-12-31 | CN¥273.05 Million ≈ $39.96 Million |
-1.52% |
| 2014-12-31 | CN¥277.26 Million ≈ $40.57 Million |
+24.69% |
| 2013-12-31 | CN¥222.36 Million ≈ $32.54 Million |
+40.38% |
| 2012-12-31 | CN¥158.40 Million ≈ $23.18 Million |
-- |
About Guiyang Xintian Pharmaceutical Co Ltd
Guiyang Xintian Pharmaceutical Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of new traditional Chinese medicines in China. The company offers products in various dosage forms, including hard capsules, oral solutions, granules, gels, tablets, syrups, tinctures, lotions, medicated wines, and elixirs. Its products are used for the treatment of … Read more